RATIO-CAPTOPRIL TAB 100MG 100 MG — DIN 00851655
CAPTOPRIL : 100 MG · RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED · TABLET · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is RATIO-CAPTOPRIL TAB 100MG?
RATIO-CAPTOPRIL TAB 100MG 100 MG contains CAPTOPRIL : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 00851655, held by RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 04-Aug-2006. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Captopril in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Captopril, across 77 DINs, of which 9 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 4 | 4 | TEVA-CAPTOPRIL | Sourceable in Canada |
| APOTEX INC | 5 | 3 | APO-CAPTO TAB 100MG, APO-CAPTO TAB 12.5MG, APO-CAPTO TAB 25MG, APO-CAPTO TAB 50MG, APO-CAPTO TAB 6.25MG | Sourceable in Canada |
| ETHYPHARM INC | 2 | 2 | NOYADA | Sourceable in Canada |
| BAKER CUMMINS INC | 4 | 0 | BCI CAPTOPRIL TABLETS | No marketed DIN |
| BRISTOL-MYERS SQUIBB CANADA | 4 | 0 | CAPOTEN TAB 100MG, CAPOTEN TAB 12.5MG, CAPOTEN TAB 25MG, CAPOTEN TAB 50MG | No marketed DIN |
| DOMINION PHARMACAL | 4 | 0 | DOM-CAPTOPRIL | No marketed DIN |
| IVAX PHARMACEUTICALS INCORPORATED | 4 | 0 | CAPTOPRIL TABLETS | No marketed DIN |
| LABORATOIRES TRIANON INC. | 4 | 0 | TRIA-CAPTOPRIL 100MG TABLET, TRIA-CAPTOPRIL 12.5MG TABLET, TRIA-CAPTOPRIL 25MG TABLET, TRIA-CAPTOPRIL 50MG TABLET | No marketed DIN |
| PRO DOC LIMITEE | 4 | 0 | CAPTOPRIL-100 TAB 100MG, CAPTOPRIL-12.5 TAB 12.5MG, CAPTOPRIL-25 TAB 25MG, CAPTOPRIL-50 TAB 50MG | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 4 | 0 | RATIO-CAPTOPRIL TAB 100MG, RATIO-CAPTOPRIL TAB 12.5MG, RATIO-CAPTOPRIL TAB 25MG, RATIO-CAPTOPRIL TAB 50MG | No marketed DIN |
| SORRES PHARMA INC | 4 | 0 | CAPTOPRIL | No marketed DIN |
| TECHNILAB PHARMA INC. | 4 | 0 | CAPTRIL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | TABLET |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Captopril |
|---|---|
| ATC code | C09AA01 |
| AHFS class | 24:32.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 00851655 |
|---|---|
| DIN (unpadded, as printed on some documents) | 851655 |
| Brand name | RATIO-CAPTOPRIL TAB 100MG |
| Generic / active ingredient | CAPTOPRIL : 100 MG |
| Market authorization holder | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | C09AA01 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C09AA |
| Current status | CANCELLED POST MARKET |
| Status date | 04-Aug-2006 |
| Original market date | 1990-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
9 of 77 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CAPTO TAB 100MG | 100 MG | TABLET | APOTEX INC | MARKETED | 00893625 |
| APO-CAPTO TAB 12.5MG | 12.5 MG | TABLET | APOTEX INC | MARKETED | 00893595 |
| APO-CAPTO TAB 50MG | 50 MG | TABLET | APOTEX INC | MARKETED | 00893617 |
| NOYADA | 5 MG / 5 ML | SOLUTION | ETHYPHARM INC | MARKETED | 02543907 |
| NOYADA | 25 MG / 5 ML | SOLUTION | ETHYPHARM INC | MARKETED | 02543915 |
| TEVA-CAPTOPRIL | 12.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 01942964 |
| TEVA-CAPTOPRIL | 25 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 01942972 |
| TEVA-CAPTOPRIL | 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 01942980 |
| TEVA-CAPTOPRIL | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 01942999 |
| APO-CAPTO TAB 25MG | 25 MG | TABLET | APOTEX INC | DORMANT | 00893609 |
2 · Same class — other molecules in ATC C09AA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Ramipril | ACH-RAMIPRIL · ACT RAMIPRIL · AG-RAMIPRIL · ALTACE · +37 more | 171 | 55 | Yes |
| Perindopril | AG-PERINDOPRIL · AG-PERINDOPRIL ERBUMINE · APO-PERINDOPRIL · APO-PERINDOPRIL ARGININE · +20 more | 81 | 54 | Yes |
| Enalapril | ACT ENALAPRIL · APO-ENALAPRIL · AVA-ENALAPRIL · DOM-ENALAPRIL · +21 more | 100 | 36 | Yes |
| Trandolapril | APO-TRANDOLAPRIL · AURO-TRANDOLAPRIL · MAVIK · MYLAN-TRANDOLAPRIL · +4 more | 40 | 25 | Yes |
| Lisinopril | ACT LISINOPRIL · APO-LISINOPRIL · APO-LISINOPRIL TABLET (TYPE P) - 10MG · APO-LISINOPRIL TABLET (TYPE P) - 20MG · +28 more | 99 | 15 | Yes |
| Captopril | APO-CAPTO TAB 100MG · APO-CAPTO TAB 12.5MG · APO-CAPTO TAB 25MG · APO-CAPTO TAB 50MG · +41 more | 77 | 9 | Yes |
| Cilazapril | APO-CILAZAPRIL · CILAZAPRIL · CO CILAZAPRIL · DOM-CILAZAPRIL · +7 more | 33 | 6 | Yes |
| Fosinopril | APO-FOSINOPRIL · AVA-FOSINOPRIL · FOSINOPRIL · FOSINOPRIL TABLETS · +14 more | 32 | 6 | Yes |
| Quinapril | ACCUPRIL 5MG TAB · ACCUPRIL TAB 10MG · ACCUPRIL TAB 20MG · ACCUPRIL TAB 40MG · +7 more | 32 | 6 | Yes |
| Benazepril | BENAZEPRIL · LOTENSIN 10MG · LOTENSIN 20MG · LOTENSIN 5MG · +1 more | 9 | 3 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is RATIO-CAPTOPRIL TAB 100MG called?
The same molecule, Captopril, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Captopril Viatris | Latin | Norway |
| Cuopril | Latin | Norway |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
What is Captopril called in other languages?
Buyers, prescribers and procurement teams outside Canada often search for the ingredient in their own script. These are phonetic renderings of the ingredient name Captopril, published to help those searches reach this page.
| Language | Captopril |
|---|---|
| Arabic العربية | كابتوبريل |
| Chinese (Simplified) 简体中文 | 卡托普利 |
| Russian Русский | каптоприл |
| Spanish Español | captopril |
| French Français | captopril |
| Portuguese Português | captopril |
| German Deutsch | captopril |
| Hindi हिन्दी | कैप्टोप्रिल |
| Persian فارسی | کاپتوپریل |
| Turkish Türkçe | kaptopril |
| Japanese 日本語 | カプトプリル |
| Vietnamese Tiếng Việt | captopril |
| Italian Italiano | captopril |
These are transliterations of the ingredient name, generated automatically and published only where two independent checks agreed. They are not registered local trade names and carry no marketing authorisation in any market. Always confirm a product against its local registration before ordering.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.